NICHD is involved in several neuroscience-related notices of funding opportunities (NOFOs), including requests for applications (RFAs), program announcements (PAs), PAs with special reviews (PARs), and notices (NOTs), including notices of special interest (NOSIs), that are now archived. Although these NOFOs are no longer active, they are provided to indicate areas of continued interest to NICHD.
Archived NOFOs related to the neurosciences
- NOT-HD-22-036 Notice of Intent to Publish a NOFO for ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
- NOT-HD-21-037 NOSI: Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19
- NOT-HD-21-032 NOSI : Reduction of Sudden Unexpected Infant Death and Sudden Infant Death Syndrome
- NOT-HD-21-026 NOSI: Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
- NOT-HD-21-025 NOSI: Reproductive Health, Pregnancy, and Parenting Among Women with Disabilities
- NOT-HD-20-032 NOSI: Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health
- NOT-HD-20-031 NOSI: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
- NOT-HD-20-026 NOSI: Optimizing Precision Treatment of Gynecologic, Reproductive and Obstetrical Outcomes in Adolescents and Adults with PCOS and Associated Comorbid Conditions (Clinical Trial Optional)
- NOT-HD-20-025 NOSI: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
- NOT-HD-20-022 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens
- NOT-HD-20-021 NOSI: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
- NOT-HD-20-004 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- PAR-20-298 Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
- PAR-20-282 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
- PAR-20-281 Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
- PAR-20-033 Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional)
- PAR-20-032 Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional)
- PAR-20-031 Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
- RFA-HD-24-004 Opportunities for Advancing Limb Regeneration Research (R01 Clinical Trial Not Allowed)
- RFA-HD-22-020 Human Milk as a Biological System (R01 Clinical Trial Optional)
- RFA-HD-22-009 Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional)
- RFA-HD-22-008 Autism Centers of Excellence: Networks (P50 Clinical Trial Optional)
- RFA-HD-22-007 Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
- RFA-HD-22-005 Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional)
- RFA-HD-21-030 Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
- RFA-HD-20-002 Pediatric HIV/AIDS Cohort Study (PHACS): 2020 (P01 Clinical Trial Not Allowed)
In addition, NICHD is also involved in the archived funding opportunities related to the NIH Blueprint for Neuroscience Research.
BACK TO TOP